+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Asia-Pacific Anesthesia Drugs Market - Segmented by Drug Type, Route of Administration, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4591600
  • Report
  • May 2018
  • Region: Asia Pacific
  • 80 pages
  • Mordor Intelligence
until Jun 30th 2020
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now


  • Abbott Laboratories
  • Astra Zeneca
  • Baxter Healthcare
  • Eisai
  • Hikma Pharmaceuticals
  • Hospira
  • MORE
The Asia-Pacific anesthesia drugs market is expected to register a CAGR of 2.9% during the forecast period (2018 - 2023). Anesthetic is a drug which causes anesthesia, a reversible loss of sensation. There are several types of anesthesia drugs available in the market such as the general anesthesia, spinal anesthesia, IV regional anesthesia, local anesthesia, peripheral nerve block, and saddle block or caudal anesthesia, etc.

Rise in the Number of Surgeries

According to a global survey which was conducted in 2010, India ranked as one of the top five nations for cosmetic, surgical, and non-surgical procedures, and according to the International Society of Aesthetic Plastic Surgery, cosmetic surgery is getting popular in countries with emerging economies, such as India and China. The overall increase in the number of surgeries performed has a strong impact on the anesthetics market since they are used in all surgical procedures to reduce the pain experienced during surgery. Along with the rise in surgeries, other factors like the emergence of new anesthetic drugs, etc., are driving the market.

Side Effects of General Anesthesia

General anesthetic drugs cause several side-effects, including nausea, vomiting, dry mouth, sore throat, shivering, muscle aches, disorientation, itching, sleepiness, and mild hoarseness. More serious complications of the drug include delirium, cognitive dysfunction, and malignant hyperthermia. General anesthetic drugs can cause physiological changes, such as blood pressure variations which require a trained anesthesiologist to monitor the patient’s blood pressure levels continuously and might have to provide blood pressure medications. Carelessness or lack of knowledge of the anesthesiologist could pose potential risks. Hence, the side-effects of general anesthesia and patient’s reluctance towards using it are restraining the segment growth. The other factors, such as lack of skilled anesthetics and regulatory issues, are also restraining the market growth.

General Anesthesia Drugs Segment to dominate the Market

The general anesthesia drugs segment has the largest market in the anesthesia drugs market. Some of the major driving forces that account for such growth in this segment are the increase in the number of general and emergency surgeries which requires the use of this general anesthesia drugs.

From the technology point of view, advancements in the development of new general anesthesia drugs are a prime driving force for this growth of the general anesthesia segment. And amongst the general anesthesia drugs, the market of Propofol is expected to dominate the general anesthesia drugs market throughout the forecast period.

Key Developments in the Market
  • September 2017: AstraZeneca made an agreement with Aspen Global Incorporated (AGI).
  • April 2017: B. Braun and Philips joined forces to innovate in ultrasound-guided regional anesthesia and vascular access.

Reasons to Purchase this Report
  • Current and future anesthesia drugs market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • Analysis on which segment is expected to dominate the market
  • Countries that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report

This report can be customized to meet your requirements..
Note: Product cover images may vary from those shown
2 of 4


  • Abbott Laboratories
  • Astra Zeneca
  • Baxter Healthcare
  • Eisai
  • Hikma Pharmaceuticals
  • Hospira
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Number of Surgeries
6.1.2 New Approvals of Anesthetic Drugs
6.1.3 Emerging Economy of Asia-Pacific Countries
6.2 Market Restraints
6.2.1 Side-Effects of General Anesthetics
6.2.2 Lack of Skilled-Anesthetics
6.2.3 Regulatory Issues
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 By Type
7.1.1 General Anesthesia Drugs Propofol Sevoflurane Desflurane Dexmedetomidine Remifentanil Midazolam Others
7.1.2 Local Anesthesia Drugs Injectable Anesthetics Surface Anesthetics
7.2 By Route of Administration
7.2.1 Inhalation
7.2.2 Injection
7.2.3 Others
7.3 By Application
7.3.1 General surgeries
7.3.2 Plastic Surgery
7.3.3 Cosmetic surgeries
7.3.4 Dental surgeries
7.3.5 Others
7.4 By Geography
7.4.1 Asia-Pacific China Japan India Australia & New Zealand South Korea Rest of Asia-Pacific

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches

9. Key Players
9.1 Baxter Healthcare
9.2 Hospira
9.3 Abbott Laboratories
9.4 Astra Zeneca
9.5 Roche Holding AG
9.6 Novartis
9.7 Pfizer
9.8 Piramal Healthcare
9.9 Eisai
9.10 Hikma Pharmaceuticals
9.11 Others
*List not exhaustive

10. Future of the Market

11. Disclaimer
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Baxter Healthcare
  • Hospira
  • Abbott Laboratories
  • Astra Zeneca
  • Roche Holding AG
  • Novartis
  • Pfizer
  • Piramal Healthcare
  • Eisai
  • Hikma Pharmaceuticals
Note: Product cover images may vary from those shown